Investors are closely monitoring the performance of Indian pharma companies in the March 2025 quarter and their ability to ...

Indian pharma stocks fell 1.6% on Monday, bucking broader market gains, after U.S. President Trump said he would cut drug ...

India's benchmark indexes are likely to open little changed on Tuesday, after logging their best day in more than four years ...

US President Trump's move to cut drug prices by 30–80% may severely impact Indian pharma exports and profitability, ...

(Reuters) -Indian pharmaceutical stocks shed 1.3% on Monday, even as the broader markets rose, after U.S. President Donald ...

Pharma sector stocks in the Indian stock market showed strong resilience on Monday despite initial pressure due to the ...

Indian pharmaceutical shares dropped up to 7% following US President Donald Trump's pledge to significantly lower US drug ...

The Nifty Pharma index gained around 2% on Tuesday, defying the broader market trend, as the Nifty slipped nearly 0.5% amid ...

Mark Mobius discusses investment strategies amidst geopolitical tensions and market dynamics. He highlights India's potential ...

Trump said he would introduce a “most favoured nation” (MFN) policy whereby the US pays “the same price as the nation that ...

As the US government, under President Donald Trump, is on the verge of announcing significant new tariffs on pharmaceutical ...

Indian pharma stocks fell 1.6% on Monday (May 12, 2025), bucking broader market gains, after U.S. President Donald Trump said he would cut drug prices by 30%–80% to match other wealthy nations.